InMed Pharmaceuticals Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q3 2024.
  • InMed Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.68M, a 33.9% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$7.68M, a 3.42% increase from 2023.
  • InMed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.95M, a 57.3% increase from 2022.
  • InMed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$18.6M, a 82.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.68M +$859K +33.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q4 2023 -$6.35M -$1.48M +$623K +29.6% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$6.97M -$2.54M +$973K +27.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$7.95M -$338K +$7.53M +95.7% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 -$15.5M -$2M +$1.48M +42.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$17M -$2.1M +$2.18M +50.9% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$19.1M -$3.51M -$539K -18.1% Jul 1, 2022 Sep 30, 2022 10-Q 2024-02-13
Q2 2022 -$18.6M -$7.87M -$4.61M -142% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-29
Q1 2022 -$14M -$3.48M -$374K -12.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$13.6M -$4.28M -$2.04M -90.9% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-17
Q3 2021 -$11.6M -$2.97M -$1.37M -85.8% Jul 1, 2021 Sep 30, 2021 10-Q 2023-02-17
Q2 2021 -$10.2M -$3.26M -$1.64M -102% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-23
Q1 2021 -$8.56M -$3.1M -$1.08M -53.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$7.48M -$2.24M +$250K +10% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$7.73M -$1.6M +$1.21M +43% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$8.94M -$1.62M Apr 1, 2020 Jun 30, 2020 10-K 2021-09-24
Q1 2020 -$2.02M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$2.49M Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$2.81M Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.